Page last updated: 2024-08-26

peptide elongation factor 2 and cyc 202

peptide elongation factor 2 has been researched along with cyc 202 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Proud, CG; Smith, EM	1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and cyc 202

Article	Year
cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. The EMBO journal, 2008, Apr-09, Volume: 27, Issue:7 Topics: Amino Acids; Animals; Biological Assay; CDC2 Protein Kinase; Cell Cycle; Cyclin B; Elongation Factor 2 Kinase; Enzyme Activation; G2 Phase; HeLa Cells; Humans; Leucine; Mice; Mitogen-Activated Protein Kinase 13; Mitosis; Models, Biological; Peptide Elongation Factor 2; Phosphorylation; Protein Kinases; Purines; Roscovitine; Serine; Substrate Specificity; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins	2008

Article

Year

cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.

The EMBO journal, 2008, Apr-09, Volume: 27, Issue:7

Topics: Amino Acids; Animals; Biological Assay; CDC2 Protein Kinase; Cell Cycle; Cyclin B; Elongation Factor 2 Kinase; Enzyme Activation; G2 Phase; HeLa Cells; Humans; Leucine; Mice; Mitogen-Activated Protein Kinase 13; Mitosis; Models, Biological; Peptide Elongation Factor 2; Phosphorylation; Protein Kinases; Purines; Roscovitine; Serine; Substrate Specificity; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2008